The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer

Singh, S; Numan, A; Maddiboyina, B; Arora, S; Riadi, Y; Md, S; Alhakamy, NA; Kesharwani, P

Arora, S (corresponding author), Chandigarh Univ, Univ Inst Pharma Sci, Mohali 140413, Punjab, India.; Kesharwani, P (corresponding author), Jamia Hamdard, Dept Pharmaceut, Sch Pharmaceut Educ & Res, New Delhi 110062, India.

DRUG DISCOVERY TODAY, 2021; 26 (7): 1721

Abstract

Triple-negative breast cancers (TNBCs) form a heterogeneous group of breast carcinomas that lack expression of estrogen receptor, progesterone recepto......

Full Text Link